2026-05-26 2026-05-26 , online online, 1,290 € plus tax CMC writing excellence: From development data to CTD content

Would you like to feel more confident presenting your CMC/quality data clearly and in full compliance with regulatory standards? Our two experts will share their extensive regulatory expertise in "advanced" CMC writing with you, providing you with real-world examples and practical tools.

Subjects
  • CMC writing conventions
  • Pharmaceutical development
  • Description of the manufacturing process and of analytical procedures
  • GMP aspects and CMC content
  • The quality part of the IND/IMPD along pre-/clinical development
  • Working with service providers and compilation of the CTD


Who should attend
Experts writing and reviewing international CMC documents will particularly benefit from this training.
It addresses the needs of those who desire to deepen their knowledge, especially on structural and conceptional details.

Participants should have prior knowledge of the content and structure of module 3.

The focus is on drug products with chemically synthetised active substances.
Objective of the event
Our comprehensive training program equips you with practical tools and expertise to confidently prepare CMC documents for CTD submission, with a strong focus on language, structure, and concept.

Following an introduction to general conventions in CMC writing our experts will guide you through considerations for creating the development plan, including specific aspects for different dosage forms: solid, liquid and sterile products.
You will learn how to compile the description of the manufacturing process correctly and receive best practices for working with service providers. You'll also gain valuable insights into the creation of CTD submissions, benefiting from real-world examples and extensive regulatory experience.

Upon completion of this seminar, you will be able to present your data clearly and in full compliance with regulatory standards, ensuring consistency and logical flow that facilitates regulatory review and approval.
Participants

After having participated in the compact course, you as "advanced" CMC writer will have learned how to

  • create the development plan;
  • how to compile the description of the manufacturing process;
  • how to work with service providers;
  • how to handle the quality part of the IND/IMPD;
  • how to create CTD-submissions.
This approach enables you to present data clearly in full regulatory compliance, maintaining consistency and logical flow that expedites regulatory review and approval.

Pharma online seminar - CMC writing excellence: From development to CTD content

CMC writing excellence:
From development to CTD content

Structure, language and best practices of quality-related documents

Benefits
  • Two experts share their extensive regulatory experience
  • Best practices, real-world examples
  • Provide your individual questions prior to the course
  • Certified according to ISO 9001 + 21001

Webcode 26072451

Book now

JETZT Buchen

Everything at a glance

Appointment

01/07/2026

01/07/2026

Period

9:00 am until 5:00 pm CET - Online training
You may dial in 30 minutes before the lecture starts

9:00 am until 5:00 pm CET - Online training
You may dial in 30 minutes before the lecture starts
Venue

online

online

Fee
Your contact

Dr. Birgit Wessels
Conference Manager

+49 6221 500-652
b.wessels@forum-institut.de

Details

Would you like to feel more confident presenting your CMC/quality data clearly and in full compliance with regulatory standards? Our two experts will share their extensive regulatory expertise in "advanced" CMC writing with you, providing you with real-world examples and practical tools.

Subjects

  • CMC writing conventions
  • Pharmaceutical development
  • Description of the manufacturing process and of analytical procedures
  • GMP aspects and CMC content
  • The quality part of the IND/IMPD along pre-/clinical development
  • Working with service providers and compilation of the CTD


Who should attend
Experts writing and reviewing international CMC documents will particularly benefit from this training.
It addresses the needs of those who desire to deepen their knowledge, especially on structural and conceptional details.

Participants should have prior knowledge of the content and structure of module 3.

The focus is on drug products with chemically synthetised active substances.

Objective of the event

Our comprehensive training program equips you with practical tools and expertise to confidently prepare CMC documents for CTD submission, with a strong focus on language, structure, and concept.

Following an introduction to general conventions in CMC writing our experts will guide you through considerations for creating the development plan, including specific aspects for different dosage forms: solid, liquid and sterile products.
You will learn how to compile the description of the manufacturing process correctly and receive best practices for working with service providers. You'll also gain valuable insights into the creation of CTD submissions, benefiting from real-world examples and extensive regulatory experience.

Upon completion of this seminar, you will be able to present your data clearly and in full compliance with regulatory standards, ensuring consistency and logical flow that facilitates regulatory review and approval.

Participants

After having participated in the compact course, you as "advanced" CMC writer will have learned how to

  • create the development plan;
  • how to compile the description of the manufacturing process;
  • how to work with service providers;
  • how to handle the quality part of the IND/IMPD;
  • how to create CTD-submissions.
This approach enables you to present data clearly in full regulatory compliance, maintaining consistency and logical flow that expedites regulatory review and approval.